¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Maximum Strength Arthritis Foundation Safety Coated Aspirin"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • dynamic strength
    1. µ¿Àû±Ù·Â 2. µ¿Àû°­µµ
  • ego strength
    ÀÚ¾ÆÈû
  • ionic strength
    À̿°­µµ
  • muscle strength
    ±ÙÀ°Èû, ±Ù·Â
  • magnetic field strength
    ÀÚÀå¼¼±â, ÀڱⰭµµ
  • physical strength
    ü·Â
  • strength
    1. ¼¼±â, °­µµ 2. Èû
  • strength duration curve
    °­µµ±â°£°î¼±
  • shearing strength
    Àü´Ü°­µµ, ¾ù°¥¸²¼¼±â
  • tearing strength
    Âõ±è°­µµ, Àο­°­µµ
  • ultimate strength
    ±ØÇѼ¼±â, ±ØÇѰ­µµ
  • wound strength
    â»ó°­µµ
  • wet strength
    ½ÀÀ±ÀÎÀå°­µµ
  • yield strength
    Ç׺¹°­µµ, Ç׺¹¼¼±â
  • ankylosing arthritis
    °­Á÷°üÀý¿°
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • maximum phonation time
    ÃÖÀå¹ß¼ºÁö¼Ó½Ã°£
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • radiation safety
    ¹æ»ç¼±¾ÈÀü
  • safety
    ¾ÈÀü, ¾ÈÀüµµ
  • safety standard
    ¾ÈÀü±âÁØ
  • arthritis
    °üÀý¿°
  • arthritis deformans
    º¯Çü°üÀý¿°
  • arthritis urethritica
    ¿äµµ¿°°üÀý¿°
  • adjuvant arthritis
    º¸Á¶°üÀý¿°
  • allergic arthritis
    ¾Ë·¹¸£±â°üÀý¿°
  • ankylosing arthritis
    °­Á÷°üÀý¿°
  • atrophic arthritis
    À§Ãà°üÀý¿°
  • climacteric arthritis
    °»³â±â°üÀý¿°
  • degenerative arthritis
    ÅðÇà°üÀý¿°
  • dry arthritis
    °Ç¼º°üÀý¿°
  • exudative arthritis
    »ïÃâ°üÀý¿°
  • gouty arthritis
    Åëdz°üÀý¿°
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • MVV=>maximum voluntary ventilation
    ÃÖ´ë ¼öÀÇȯ±â·®
  • Tm => transport maximum
    ÃÖ´ëÀ̵¿Ä¡
  • apex beat =point of maximum impulse
    ½É÷¹Úµ¿(ãýôÓÚÑÔÑ)
  • Charcots arthritis
    »þ¸£ÄÚ °üÀý¿°(~Î¼ï½æú).
  • Charcots arthritis
    »þ¸£ÄÚ°üÀý¿°.
  • acute arthritis
    ±Þ¼º °üÀý¿°(ÐáàõÎ¼ï½æú).
  • acute bacterial arthritis
    ±Þ¼º ¼¼±Õ¼º °üÀý¿°(Ðáàõá¬Ð¶àõÎ¼ï½æú).
  • acute bacterial arthritis
    ±Þ¼º ¼¼±Õ¼º °üÀý¿°(¡­á¬Ð¶àõÎ¼ï½æú).
  • acute rheumatic arthritis
    ±Þ¼º·ù¸¶Æ¼½º¼º °üÀý¿°
  • acute rheumatic arthritis<³ª> a. rheumatica acu ta
    ±Þ¼º ·ù¸¶Æ¼½º¼º °üÀý¿°.
  • acute rheumatic arthritis<³ª> a. rheumatica acuta
    ±Þ¼º ·ù¸¶Æ¼½º¼º °üÀý¿°.
  • adjuvant arthritis
    º¸Á¶ °üÀý¿°(ÜÍð¾Î¼ï½æú), ¾ÖÁÖ¹øÆ®°üÀý¿°(¡­Î¼ï½æú).
  • allergic arthritis
    °ú¹Î¼º °üÀý¿° (ΦÚÂàõÎ¼ï½æú), ¾Ë·¯Áö °üÀý¿°, ¾Ë·¹¸£±â(¼º) °üÀý¿° (¡­Î¼ï½æú).
  • ankylosing arthritis
    °­Á÷¼º °üÀý¿°(Ë­òÁàõÎ¼ï½æú).
  • arthritis
    °üÀý¿°(¡­æú).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • minimum safety pressure
    ÃÖ¼Ò¾ÈÀü¾Ð.
  • pop valve =safety v.
    ¾ÈÀüÆÇ(äÌîï÷û).
  • protective spectacles =safety goggles
    ¹æÈ£¾È°æ(ËÑÌ´ËâË­).
  • radiation safety
    ¹æ»ç¼±¾ÈÀü
  • safety cabinet
    ¹«±Õ½ÇÇè´ë, ¾ÈÀü½ÇÇè´ë
  • safety control
    ¾ÈÀü°ü¸®(ËâËøË´Ëö).
  • safety factor
    ¾ÈÀüÀ².
  • safety lens
    ¾ÈÀü·»Áî
  • safety precaution
    ¾ÈÀüÁöħ
  • safety procedure
    ¾ÈÀüÀýÂ÷
  • safety-seeking, Horneys concept
    ¾ÈÀüÃß±¸(HorneyÀÇ °³³ä¿¡¼­)
  • seat (safety) belts
    ¾ÈÀü¶ì
  • back strength
    ¹è±Ù·Â.
  • bending strength
    ±¼°î °­µµ(ÏÝÍØË­Óø).
  • bonding strength
    °áÇÕ·Â(Ì¿ùêæ³).
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • gouty arthritis
    Åëdz¼º°üÀý¿°
  • hypertrophic arthritis
    ºñÈļº°üÀý¿°
  • juvenile rheumatoid arthritis
    ¿¬¼Ò¼º·ù¸¶Æ¼½º¾ç°üÀý¿°
  • mycotic arthritis
    Áø±Õ¼ºÇǺο°
  • proliferative arthritis
    Áõ½Ä¼º°üÀý¿°
  • pyogenic arthritis
    È­³ó¼º°üÀý¿°
  • rheumatic arthritis
    ·ù¸¶Æ¼½º¼º°üÀý¿°
  • rheumatoid arthritis
    ·ù¸¶Æ¼½º¾ç°üÀý¿°
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
AHF acute heart failure; American Health Foundation; American Hepatic Foundation; American Hospital Form...
NPF nasopharyngeal fiberscope; National Parkinson Foundation; National Pharmaceutical Foundation; Nation...
CS calf serum; campomelic syndrome; carcinoid syndrome; cardiogenic shock; caries-susceptible; carotid ...
TS Takayasu syndrome; Tay-Sachs; temperature sensitivity; temperature, skin; temporal stem; tensile str...
US/LS upper strength/lower strength [ratio]
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
JDF-U Juvenile Diabetes Foundation Units
NKF DOQI National Kidney Foundation Dialysis Outcomes Quality Initiative
RERF Radiation Effect Research Foundation
SEOPF South Eastern Organ Procurement Foundation
ACB Antibody-coated bacteria
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • safety education
    ¾ÈÀü ±³À°
    ¾ÈÀüÇÑ »ýȰÀ» ÇÒ ¼ö ÀÖµµ·Ï ÇÊ¿äÇÑ Áö½ÄÀ» ÁÖ´Â °Í.
  • safety factor
    ¾ÈÀü·ü
    ½Å°æ ¼¶À¯³ª ±Ù¼¶À¯ÀÇ ÈïºÐ Á¤µµ¿¡ À־ ÀÌ¹Ì ÈïºÐÇÑ °÷¿¡¼­, ¾ÆÁ÷ ÈïºÐÇϰí ÀÖÁö ¾ÊÀº ºÎºÐÀ¸·Î Àü·ù°¡ È帧À¸·Î½á ÈïºÐÀÌ ÀüµµÇϴµ¥, ÀÌ Àü·ù°¡ ½ÇÁ¦·Î ÈïºÐ½Ã۴µ¥ ÇÊ¿äÇÑ Àü·ù°ª.
  • safety inspection
    ¾ÈÀü °¨½Ã
    ¸ðµç »ýȰ ȯ°æ¿¡¼­ ¾ÈÀü °ü¸®¸¦ ¸ñÀûÀ¸·Î ÇÑ´Ù. ÀÏ¹Ý »ýȰ ȯ°æ, ³ëµ¿ ȯ°æ ¹× Çб³ ȯ°æ µî, ¸ðµç »ýȰ ȯ°æ¿¡¼­ÀÇ ¾ÈÀü °ü¸®¸¦ ¸ñÀûÀ¸·Î ÀÏ¹Ý °øÁß À§»ý ÇàÁ¤ÀÇ ºÐ¾ß¿¡¼­´Â º¸°Çº¹ÁöºÎ°¡, ³ëµ¿À§»ý ÇàÁ¤ÀÇ ºÐ¾ß¿¡¼­´Â ³ëµ¿ºÎ°¡, Çб³À§»ý ÇàÁ¤ÀÇ ºÐ¾ß¿¡¼­´Â ±³À°ºÎ°¡ Áß½ÉÀÌ µÇ¾î ȯ°æ °¨½Ã Ȱµ¿À» Çϰí ÀÖ´Ù.
  • safety measure
    ¾ÈÀüÃ¥
  • safety pipetter
    ¾ÈÀü ÇÇÆäÅÍ
    ¾×üÀÇ À̵¿À» ¶³¾îÁ®¼­ ÇàÇϱâ À§ÇØ »ç¿ëÇÏ´Â ÇÇÆê.
  • safety regulation and standard
    ¾ÈÀü Á¶Àý ¹× Ç¥ÁØ
  • safety supervisor
    ¾ÈÀü °ü¸®ÀÚ
    ³ëµ¿¾ÈÀü À§»ý¹ýÀ¸·Î ¼±ÀÓµÈ ¾ÈÀüº¸¾È ´ã´çÀÚ.
  • safety valve
    ¾ÈÀü ÆÇ
  • school safety
    Çб³ ¾ÈÀü
    ÇлýÀÇ ¾ÈÀüÀ» À§ÇÑ ¾ÈÀü ±³À°°ú ¾ÈÀü °ü¸®.
  • bending strength
    ±¼°î °­µµ, ±ÁÈû °­µµ
    º¸¿¡ »ý±â´Â ÃÖ´ë ±ÁÈû ÀÀ·Â.
  • compressive strength
    ¾ÐÃà °­µµ
    ¾ÐÃà ½ÃÇè¿¡ À־ Àç·á°¡ ÆÄ±«µÇ¾úÀ» ¶§ÀÇ ÇÏÁßÀ», ½ÃÇèÆíÀÇ ÃÖ¼Ò ´Ü¸éÀûÀ¸·Î ³ª´« °ÍÀ¸·Î, Àç·á°¡ ¾ÐÃà·ÂÀ» ¹ÞÀ» ¶§ ÀúÇ×ÇÏ´Â Èû.
  • edge strength
    ¿¬´Ü °­µµ
    ÆÄ¼â·Â¿¡ ´ëÇÑ ÃæÀü¹° º¯¿¬ÀÇ ÀúÇ×·Â.
  • field strength
    ÀÚÀå ¼¼±â, ÀÚÀå·Â
  • fired strength
    ¼Ò¼º °­µµ
  • flexure strength
    ¿ä°î °­µµ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
enteric-coated A term designating a special coating applied to tablets or capsules which prevents release and absorption of their contents until they reach the intestines.
(18 Nov 1997)
enteric coated tablet An oral dosage form in which a tablet is coated with a material to prevent or minimise dissolution in the stomach but allow dissolution in the small intestine. This type of formulation either protects the stomach from a potentially irritating drug (e.g., aspirin) or protects the drug (e.g., erythromycin) from partial degradation in the acidic environment of the stomach.
(05 Mar 2000)
maximum 1. The greatest possible or actual effect or quantity.
2. The acme of a disease or process.
(18 Nov 1997)
maximum breathing capacity The volume of air breathed when an individual breathes as deeply and as quickly as possible for a given time (e.g., 15 sec.).
Synonym: maximum breathing capacity.
(05 Mar 2000)
maximum occipital point The point on the squama of the occipital bone farthest from the glabella.
(05 Mar 2000)
maximum permissible dose <radiobiology> Defined by the International Commission on Radiological Protection as the greatest dose of radiation which, in the light of present knowledge, is not expected to cause detectable bodily injury to a person at any time during his lifetime.
This dose has been reduced with each Commission report. The MPD is given in terms of acute or chronic exposure of the whole body or of organs, systems, or regions of the body, and differs for persons who are occupationally exposed versus the public at large.
(05 Mar 2000)
maximum permissible exposure level The highest level of exposure to a substance, usually noxious, in the environment or during diagnostic and therapeutic procedures, that a body can tolerate without injury.
(12 Dec 1998)
maximum temperature In bacteriology, denoting a temperature above which growth will not take place.
(05 Mar 2000)
maximum urea clearance The urea clearance when the urine flow exceeds 2 ml/min; normal value is about 75 ml blood/min per 1.73 m2 body surface area.
(05 Mar 2000)
maximum velocity The maximum rate of an enzyme-catalyzed reaction that can be achieved by progressively increasing the substrate concentration at a given enzyme concentration; in cases of substrate inhibition, Vmax is an extrapolated value in the absence of such inhibition; Cf.: Michaelis-Menten equation.
The maximum initial rate of shortening of a myocardial fibre that can be obtained under zero load; used to evaluate the contractility of the fibre.
(05 Mar 2000)
maximum voluntary ventilation The volume of air breathed when an individual breathes as deeply and as quickly as possible for a given time (e.g., 15 sec.).
Synonym: maximum breathing capacity.
(05 Mar 2000)
tubular maximum transport maximum
associative strength In psychology, the strength of a stimulus response linkage as measured by the frequency with which a stimulus elicits a particular response.
See: conditioning.
(05 Mar 2000)
biting strength The motive force created by the dynamic action of the muscles during the physiologic act of mastication.
Synonym: biting strength, masticatory force.
(05 Mar 2000)
compressive strength The maximum compression a material can withstand without failure.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • strength
    Èû;°­Çϱâ;°­µµ;³óµµ;º´·Â;È¿·Â;ÀúÇ×(³»±¸)·Â;ÈûÀÌ µÇ´Â °Í;ÀÇÁö;on the ~ of;...À» ÀÇÁöÇÏ¿©(¹Ð°í)
  • foundation
    â¼³
  • Foundation Day
    =AUSTRALIA DAY
  • Nobel Foundation
    ³ëº§Àç´Ü
  • Rockefeller Foundation
    ·ÏÆç·¯ Àç´Ü
  • foundation
    Åä´ë;±âÃÊ;±Ù°Å;â¼³;¼³¸³
  • foundation cream
    ¹ØÈ­Àå Å©¸²
  • foundation garment
    (¸ö¸Å¸¦ ¸Ê½ÃÀÖ°Ô ÇÏ´Â) ¿©ÀÚ¿ë ¼Ó¿Ê
  • foundation muslin
    ¾È°¨¿ë ¸ð½½¸°
  • foundation school
    Àç´Ü ¼³¸³ Çб³
  • foundation stone
    ÁÖÃåµ¹;Ãʼ®
  • safety
    ¾ÈÀü
  • free safety
    ÇÁ¸® ¼¼ÀÌÇÁƼ
  • safety
    ¾ÈÀü;¾ÈÀü±â(°ü);in ~ ¾ÈÀü(¹«»ç)È÷;play for ~ ¾ÈÀüÀ» ±âÇÏ´Ù
  • safety belt
    ±¸¸í´ë;(Á¼®ÀÇ) ¾ÈÀüº§Æ®
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á